NL-OMON41078CompletedNot Applicable
The effect of dairy consumption on metabolic flexibility and glucose metabolism - Dairy intake and metabolic flexibility
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 50
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 to 99 (—)
Inclusion Criteria
- •1. Healthy male or postmenopausal female
- •2. Middle-aged: between 45 and 65 yrs of age
- •3. BMI >= 25 to <= 30 kg/m2
- •4. Low-medium dairy consumer (based on VCP, assessed by questionnaire on health and lifestyle)
- •5. Used to consume 3 main meals a day including breakfast
- •6. Not involved in intensive sportive activities more than twice a week (e.g. playing football, tennis, running, race-cycling, swimming)
- •7. Stable weight and no intention to lose weight until completion of the study
- •8. Able to participate and willing to comply with study procedures and restrictions
- •9. Signed written informed consent form (ICF)
Exclusion Criteria
- •1. Diabetes mellitus (based on fasting glucose and HbA1c-values at screening)
- •2. Clinically relevant abnormalities in blood lipids (total cholesterol > 8 mmol/L, triglycerides > 6 mmol/L, LDL >5,7 mmol/L) at screening
- •3. Clinically relevant abnormalities in hematology (ao Hb < 8,7 mmol/L ) at screening
- •4. Clinically relevant abnormalities in markers for liver (ALAT, ASAT) and kidney (creatinine-albumin ratio, urine) damage at screening
- •5. Positive HIV, HbsAg and/or HepC at screening
- •6. Not being able to fast overnight (12 hours)
- •7. Unable to resign from smoking during test day (12h) without symptoms of withdrawal
- •8. Gastrointestinal disorders or undergone digestive tract surgery (except appendectomy)
- •9. Intake of nutritional supplements (from screening until the end of the study)
- •10. Use of medication that would interfere with the study parameters: oral anti-diabetics, insulin, lipid-lowering drugs (from screening until the end of the study) and anti-biotics (from 1 month before screening)
- •11. Reported slimming or medically prescribed diet
- •12. Reported vegan, vegetarian or macrobiotic life-style
- •13. A reported food allergy or sensitivity (e.g. lactose)
Investigators
Similar Trials
Completed
Not Applicable
The effect of dairy consumption on metabolism and health.Insulin resistance, Type 2 Diabetes Mellitus, metabolic health.Insuline resistentie, Type 2 Diabetes Mellitus, metabole gezondheid.NL-OMON20152Public-Private Partnership-TKI Agro & FoodProject: ‘Basisvoedingsmiddelen- en gedragsinterventies in relatie tot behoud van gezondheid’ (TKI-AF-12104)Partners deelproject ao UMCG, FrieslandCampina.52
Completed
Not Applicable
Dairy Products and Metabolic Effects (Norwegian Part)Metabolic Syndrome XHeart DiseaseNCT00140816Oslo University Hospital40
Completed
Not Applicable
Effect of dairy product on lipid profile, stress oxidative and inflammatory markersDiabetic patients.Malnutrition-related diabetes mellitusIRCT201207261640N8Research Institute for Endocrine Sciences, Shahid Beheshti University of medical Sciences90
Completed
Not Applicable
The effect of dairy fat on metabolic healthObesityISRCTN86731958Food for Health Ireland240
Not yet recruiting
Not Applicable
The effect of high consumption of dairy on women's weight lossOverweight.Overweight and obesityIRCT20201102049229N1Tehran University of Medical Sciences60